- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04301232
Fast-Track Eligibility and Hospital Discharge for Outpatient Lumbar Discectomy
March 5, 2020 updated by: Mehmet Burak Eşkin, Gulhane School of Medicine
Fast-Track Eligibility and Hospital Discharge for Outpatient Lumbar Discectomy: A Prospective Observational Study
122 ASA I-II patients were enrolled into the study.
IV propofol, fentanyl and rocuronium were used for the induction and a total intravenous anesthesia technique for the maintenance of anesthesia.
Sugammadex was given for neuromuscular blockade reversal.
A multi-modal analgesic regimen was utilized.
Primary outcome measures were PACU bypass rates and hospital discharge times.
Secondary outcome measure was to compare discharge scoring systems for PACU bypass assessment: modified Aldrete Scoring System (mASS), White's Fast-Tracking Scoring System (WFTSS), and SPEEDS criteria
Study Overview
Status
Completed
Conditions
Detailed Description
After obtaining hospital's ethics committee approval (University of Medical Sciences, Gülhane Training and Research Hospital- Date: 06/05/2018; No: 18/148) and written informed consents obtained from patients, 122 ASA (American Society of Anesthesiologists) physical status I-II patients, aged between 18-65 years, undergoing elective lumbar discectomy under general anesthesia were included into the study .
After anesthesia application applied to all groups with the same procedure, patients were extubated after surgery.
After extubation, patients were evaluated using mASS, WFTSS and SPEEDS criteria during 15 minutes with 3 min intervals.
Patients who fulfilled criteria of all scoring systems were defined as eligible for PACU by-pass (fast-tracking) and transferred into phase II recovery area in the ward without observation in PACU (Group FT = Fast Track;).
Ineligible patients were taken into PACU where their treatments were continued until discharge criteria were achieved (Group PACU).
All patients were followed in the ward until hospital discharge.
IV tramadol PCA (Patient -Controlled Analgesia; infusion rate: 4 mgh-1, bolus dose: 4mg, lock-out time: 30 min., 4 hours-limit: 30 mg), paracetamol (10 mgkg-1 IV with 6 hrs.
intervals) and oral diclofenac sodium (75 mg with 8 hrs.
intervals) were given in a multimodal analgesic regimen.
Pain was evaluated using Visual Analogue Scale (VAS) with 2 hours intervals and IV pethidine 0.5 mgkg-1 was given as rescue analgesic throughout the study period when VAS was >3.
PONV was treated using IV 4 mg ondansetron.
Discharge from hospital was evaluated using Post Anesthetic Discharge Scoring System (PADSS), .
Patients with a PADSS score ≥ 9 were discharged from the hospital by the escort of their relatives.
Study Type
Observational
Enrollment (Actual)
122
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Çankaya/ANKARA
-
Ankara, Çankaya/ANKARA, Turkey, 06010
- Çankaya Hospital, Department of Anesthesiology and Reanimation, Ankara, Turkey
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
122 ASA (American Society of Anesthesiologists) physical status I-II patients, aged between 18-65 years, undergoing elective lumbar discectomy under general anesthesia were included into the study.
Description
Inclusion Criteria:
- ASA (American Society of Anesthesiologists) physical status I-II patients
- elective primary lumbar discectomy performed for one or two vertebra levels under general anesthesia
- minimal risks for perioperative bleeding and airway safety
Exclusion Criteria:
- patient's refusal
- urgent surgery,
- regional anesthesia,
- history of previous lumbar surgery
- difficult ventilation and intubation,
- treatment for chronic pain
- obstructive sleep apnea,
- morbid obesity (BMI≥40 kg/m2)
- allergy to drugs
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Fast-Track Group
After extubation, patients were evaluated using modified Aldrete Scoring System (mASS) , White's Fast- Track Scoring System (WFTSS) and SPEEDS criteria during 15 minutes with 3 min intervals.
Patients who fulfilled criteria of all scoring systems were defined as eligible for PACU by-pass (fast-tracking) and transferred into phase II recovery area in the ward without observation in PACU (Group FT = Fast Track;)
|
Activity( Moves all extremities, Moves two extremities, Unable to move extremities), Respiration( Breathes deeply, coughs freely, Dyspneic, shallow or limited breathing, Apneic), Circulation (blood pressure) ( 20 mm Hg > preanesthetic level, 20 - 50 mm Hg > preanesthetic level, 50 mm Hg > preanesthetic level), Consciousness (Fully awake, Arousable on calling, Not responding), Oxygen saturation( SpO2 > 92% on room air, Supplemental O2 required to maintain SpO2 > 90%,SpO2 < 90% with O2 supplementation), scoring is done as 2,1,0, respectively.
A score of 9 or more would be required for a patient after general anesthesia for discharge
Physical activity (Able to move all extremities on command, ,Some weakness in movement of extremities, Unable to voluntarily move extremities),Respiratory stability(Able to breathe deeply,Tachypnea,Dyspneic),Hemodynamic stability; (Blood pressure(MAP)<15%, Blood pressure 15-30%, Blood pressure>30%, Level of consciousness,(Awake&orientated Arousable with minimal stimulation, Responsive only to tactile stimulation),Oxygen saturation status(Maintains value>90% on room air, Requires supplemental oxygen, Saturation<90% with supplemental oxygen), Postoperative pain assessment(None or mild discomfort, Moderate to severe pain controlled with analgesics, Persistent severe pain), Postoperative emetic symptoms(None or mild nausea w/no active vomiting, Transient vomiting or retching, Persistent moderate to severe nausea&vomiting), Scoring is done as 2,1,0, respectively.
A minimal score of 12(with no score<1 in any individual category)would be required for a patient after general anesthesia
Extremity movement (moves all four) Y/N, Stable vital signs( SBP > 90 and < 180, HR > 50 and < 110) Y/N, Dialogue (oriented person/place) Y/N, Oxygen saturation >90% in roExtremity movement (moves all four) Y/N, Stable vital signs( SBP > 90 and < 180, HR > 50 and < 110) Y/N, Dialogue (oriented person/place) Y/N, Oxygen saturation >90% in room air Y/N, Pain Control (VAS < 4) Y/N, Emesis Control Y/N.
A patient must have a response of "yes" to all parameters to progress to phase II recovery
|
PACU Group
After extubation, patients were evaluated using modified Aldrete Scoring System (mASS) , White's Fast- Track Scoring System (WFTSS) and SPEEDS criteria during 15 minutes with 3 min intervals.
Ineligible patients were taken into PACU where their treatments were continued until discharge criteria were achieved (Group PACU)
|
Activity( Moves all extremities, Moves two extremities, Unable to move extremities), Respiration( Breathes deeply, coughs freely, Dyspneic, shallow or limited breathing, Apneic), Circulation (blood pressure) ( 20 mm Hg > preanesthetic level, 20 - 50 mm Hg > preanesthetic level, 50 mm Hg > preanesthetic level), Consciousness (Fully awake, Arousable on calling, Not responding), Oxygen saturation( SpO2 > 92% on room air, Supplemental O2 required to maintain SpO2 > 90%,SpO2 < 90% with O2 supplementation), scoring is done as 2,1,0, respectively.
A score of 9 or more would be required for a patient after general anesthesia for discharge
Physical activity (Able to move all extremities on command, ,Some weakness in movement of extremities, Unable to voluntarily move extremities),Respiratory stability(Able to breathe deeply,Tachypnea,Dyspneic),Hemodynamic stability; (Blood pressure(MAP)<15%, Blood pressure 15-30%, Blood pressure>30%, Level of consciousness,(Awake&orientated Arousable with minimal stimulation, Responsive only to tactile stimulation),Oxygen saturation status(Maintains value>90% on room air, Requires supplemental oxygen, Saturation<90% with supplemental oxygen), Postoperative pain assessment(None or mild discomfort, Moderate to severe pain controlled with analgesics, Persistent severe pain), Postoperative emetic symptoms(None or mild nausea w/no active vomiting, Transient vomiting or retching, Persistent moderate to severe nausea&vomiting), Scoring is done as 2,1,0, respectively.
A minimal score of 12(with no score<1 in any individual category)would be required for a patient after general anesthesia
Extremity movement (moves all four) Y/N, Stable vital signs( SBP > 90 and < 180, HR > 50 and < 110) Y/N, Dialogue (oriented person/place) Y/N, Oxygen saturation >90% in roExtremity movement (moves all four) Y/N, Stable vital signs( SBP > 90 and < 180, HR > 50 and < 110) Y/N, Dialogue (oriented person/place) Y/N, Oxygen saturation >90% in room air Y/N, Pain Control (VAS < 4) Y/N, Emesis Control Y/N.
A patient must have a response of "yes" to all parameters to progress to phase II recovery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Duration of the surgery
Time Frame: at the end of the surgery
|
the period (minutes) from the beginning of the surgery to the end of surgery
|
at the end of the surgery
|
time to extubation
Time Frame: 1 hour after extubation
|
the period (minutes) from the end of surgery until extubation
|
1 hour after extubation
|
PACU( post-anesthesia care unit) by-pass rate
Time Frame: 1 weeks after discharge from the hospital
|
The period (minutes) from admission to post-anesthesia care unit to discharge from the clinic
|
1 weeks after discharge from the hospital
|
Time to hospital discharge
Time Frame: 1 weeks after discharge from the hospital
|
The period (hours) from hospital admission to hospital discharge.
|
1 weeks after discharge from the hospital
|
Time to PACU by-pass in group FT
Time Frame: 1 weeks after discharge from the hospital
|
time(minutes) to be eligible for PACU by-pass in group FT according to scoring systems
|
1 weeks after discharge from the hospital
|
time to PACU care in group PACU
Time Frame: 1 weeks after discharge from the hospital
|
duration (minutes) of PACU care for patients in group PACU
|
1 weeks after discharge from the hospital
|
patients who were eligible for fast-tracking
Time Frame: through study completion, an average of 2 weeks
|
number patients who were eligible for fast-tracking
|
through study completion, an average of 2 weeks
|
patients who were discharged from hospital
Time Frame: through study completion, an average of 2 weeks
|
number patients who were discharged from hospital with respect to outpatient surgery (discharge time < 24 hours)
|
through study completion, an average of 2 weeks
|
factors preventing
Time Frame: through study completion, an average of 2 weeks
|
factors preventing fast-tracking and/or discharge from hospital in outpatient setting
|
through study completion, an average of 2 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Mehmet Ö ÖZHAN, M.D., Çankaya Hospital, Department of Anesthesiology and Reanimation, Ankara, Turkey
- Principal Investigator: Mehmet B. EŞKİN, M.D., Gulhane Training and Research Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 10, 2018
Primary Completion (Actual)
December 12, 2019
Study Completion (Actual)
January 28, 2020
Study Registration Dates
First Submitted
March 4, 2020
First Submitted That Met QC Criteria
March 5, 2020
First Posted (Actual)
March 10, 2020
Study Record Updates
Last Update Posted (Actual)
March 10, 2020
Last Update Submitted That Met QC Criteria
March 5, 2020
Last Verified
March 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 18/148
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Op Complication
-
Rigshospitalet, DenmarkCompletedComplication,Postoperative | Post-Op ComplicationDenmark
-
Centre Hospitalier Universitaire, AmiensCentre Hospitalier Universitaire de Caen; Centre Hospitalier VALENCIENNES; st...CompletedRespiratory Complication | Post-Op ComplicationFrance
-
St. Anne's University Hospital Brno, Czech RepublicRecruiting
-
Centre Hospitalier Universitaire VaudoisNot yet recruitingPost-Op ComplicationSwitzerland
-
University of Alabama at BirminghamCompletedPost-Op ComplicationUnited States
-
Riphah International UniversityCompletedPost-Op ComplicationPakistan
-
Alexa CraigMaineHealthCompletedPost-Op ComplicationUnited States
-
Centre Hospitalier Régional Metz-ThionvilleCompletedPost-Op ComplicationFrance
-
NYU Langone HealthCompleted
-
Rothman Institute OrthopaedicsUnknown
Clinical Trials on Modified Aldrete Scoring System (mASS)
-
Kanuni Sultan Suleyman Training and Research HospitalCompletedDevelopment of Modified Combined Apgar Scoring System for Evaluation of Infants in the Delivery RoomNeonatal Respiratory FailureTurkey
-
Seoul National University HospitalUnknownScleroderma, SystemicKorea, Republic of
-
Dokuz Eylul UniversityNot yet recruitingAtelectasis, Postoperative Pulmonary
-
Assiut UniversityCompletedInduction of Labor Affected Fetus / NewbornEgypt
-
Assiut UniversityNot yet recruiting
-
Shanghai Pulmonary Hospital, Shanghai, ChinaUnknownCryptococcosis | Lung AdenocarcinomaChina
-
University of Wisconsin, MadisonCompleted
-
Shandong UniversityUnknown
-
Guy's and St Thomas' NHS Foundation TrustPfizerUnknownModerate and Severe Haemophilia
-
Fondazione Policlinico Universitario Agostino Gemelli...Completed